Follow
Siddik Sarkar
Title
Cited by
Cited by
Year
Targeting Mcl-1 for the therapy of cancer
BA Quinn, R Dash, B Azab, S Sarkar, SK Das, S Kumar, RA Oyesanya, ...
Expert opinion on investigational drugs 20 (10), 1397-1411, 2011
2542011
Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water
SM Mandal, S Dey, M Mandal, S Sarkar, S Maria-Neto, OL Franco
Peptides 30 (4), 633-637, 2009
1782009
Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer
S Rajput, BNP Kumar, S Sarkar, S Das, B Azab, PK Santhekadur, SK Das, ...
PLoS One 8 (4), e61342, 2013
1402013
ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells
S Sarkar, A Mazumdar, R Dash, D Sarkar, PB Fisher, M Mandal
Cancer biology & therapy 9 (8), 592-603, 2010
1092010
Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression
N Puvvada, S Rajput, BNP Kumar, S Sarkar, S Konar, KR Brunt, RR Rao, ...
Scientific reports 5, 11760, 2015
902015
Enzyme/Prodrug Systems for Cancer Gene Therapy
OM Malekshah, X Chen, A Nomani, S Sarkar, A Hatefi
Current pharmacology reports 2 (6), 299-308, 2016
872016
Crosslinking of gelatin-based drug carriers by genipin induces changes in drug kinetic profiles in vitro
G Thakur, A Mitra, D Rousseau, A Basak, S Sarkar, K Pal
Journal of Materials Science: Materials in Medicine 22 (1), 115-123, 2011
842011
Overcoming Akt induced therapeutic resistance in breast cancer through siRNA and thymoquinone encapsulated multilamellar gold niosomes
S Rajput, N Puvvada, BNP Kumar, S Sarkar, S Konar, R Bharti, G Dey, ...
Molecular pharmaceutics 12 (12), 4214-4225, 2015
772015
Structural identification and cytotoxic activity of a polysaccharide from the fruits of Lagenaria siceraria (Lau)
K Ghosh, K Chandra, AK Ojha, S Sarkar, SS Islam
Carbohydrate research 344 (5), 693-698, 2009
722009
Biomarkers for the diagnosis of thyroid cancer
K Sethi, S Sarkar, S Das, B Mohanty, M Mandal
J Exp Ther Oncol 8 (4), 341-52, 2010
632010
Novel mechanism of MDA-7/IL-24 cancer-specific apoptosis through SARI induction
R Dash, P Bhoopathi, SK Das, S Sarkar, L Emdad, S Dasgupta, D Sarkar, ...
Cancer research 74 (2), 563-574, 2014
592014
The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance
BC Jena, S Sarkar, L Rout, M Mandal
Cancer Letters, 2021
572021
Enhanced delivery of mda‐7/IL‐24 using a serotype chimeric adenovirus (Ad. 5/3) in combination with the apogossypol derivative BI‐97C1 (Sabutoclax) improves therapeutic …
B Azab, R Dash, SK Das, SK Bhutia, XN Shen, BA Quinn, S Sarkar, ...
Journal of cellular physiology 227 (5), 2145-2153, 2012
542012
Pancreatic cancer combination therapy using a BH3 mimetic and a synthetic tetracycline
BA Quinn, R Dash, S Sarkar, B Azab, P Bhoopathi, SK Das, L Emdad, ...
Cancer research 75 (11), 2305-2315, 2015
472015
AEG-1 Promoter–Mediated Imaging of Prostate Cancer
A Bhatnagar, Y Wang, RC Mease, M Gabrielson, P Sysa, I Minn, G Green, ...
Cancer research 74 (20), 5772-5781, 2014
472014
Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic
R Dash, B Azab, XN Shen, UK Sokhi, S Sarkar, Z Su, XY Wang, ...
Discovery medicine 11 (56), 46, 2011
472011
Micellear Gold Nanoparticles as Delivery Vehicles for Dual Tyrosine Kinase Inhibitor ZD6474 for Metastatic Breast Cancer Treatment
S Sarkar, S Konar, PN Prasad, S Rajput, BNP Kumar, RR Rao, A Pathak, ...
Langmuir 33 (31), 7649-7659, 2017
402017
Abrus agglutinin is a potent anti‐proliferative and anti‐angiogenic agent in human breast cancer
SK Bhutia, B Behera, D Nandini Das, S Mukhopadhyay, N Sinha, ...
International journal of cancer 139 (2), 457-466, 2016
402016
Cancer terminator viruses and approaches for enhancing therapeutic outcomes
SK Das, S Sarkar, R Dash, P Dent, XY Wang, D Sarkar, PB Fisher
Advances in cancer research 115, 1-38, 2012
402012
Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma
K Sethi, S Sarkar, S Das, S Rajput, A Mazumder, B Roy, S Patra, ...
J Exp Ther Oncol 9 (3), 187-199, 2011
402011
The system can't perform the operation now. Try again later.
Articles 1–20